2022
DOI: 10.1161/strokeaha.121.034786
|View full text |Cite
|
Sign up to set email alerts
|

Endovascular Treatment for Posterior Circulation Stroke in Routine Clinical Practice: Results of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry

Abstract: BACKGROUND AND PURPOSE: The benefit of endovascular treatment (EVT) for posterior circulation stroke (PCS) remains uncertain, and little is known on treatment outcomes in clinical practice. This study evaluates outcomes of a large PCS cohort treated with EVT in clinical practice. Simultaneous to this observational study, several intervention centers participated in the BASICS trial (Basilar Artery International Cooperation Study), which tested the efficacy of EVT for basilar artery occlusion in a r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 29 publications
0
12
0
Order By: Relevance
“…Basilar artery occlusion (BAO) accounts for 1% of ischemic strokes and 10% of large artery occlusions and is associated with high morbidity and mortality [ 1 , 2 ]. Pooled analysis has demonstrated the benefit of endovascular therapy (EVT) for patients with acute BAO [ 3 , 4 ]. Although the recent randomized trials failed to verify the superiority of EVT over standard medical therapy in patients with acute BAO, a substantial benefit of EVT could not be excluded because of inherent limitations of the two trials, such as high crossover rate [ 5 ] and poor recruitment [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Basilar artery occlusion (BAO) accounts for 1% of ischemic strokes and 10% of large artery occlusions and is associated with high morbidity and mortality [ 1 , 2 ]. Pooled analysis has demonstrated the benefit of endovascular therapy (EVT) for patients with acute BAO [ 3 , 4 ]. Although the recent randomized trials failed to verify the superiority of EVT over standard medical therapy in patients with acute BAO, a substantial benefit of EVT could not be excluded because of inherent limitations of the two trials, such as high crossover rate [ 5 ] and poor recruitment [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, there are some large studies did not confirm that intravascular interventional therapy in the time window is superior to medical treatment alone for acute posterior circulation large-vessel occlusion stroke, including the BEST [ 19 ] and BASICS studies [ 20 ]. It is worth noting that the inclusion and exclusion criteria of the above studies were different, and different inclusion and exclusion criteria may lead to different and invalid recanalization rates, thus making the intravascular interventional treatment of posterior circulation large vessel occlusion cerebral infarction ambiguous in clinical practice [ 21 ]. Therefore, we consider that there are significant influencing factors for ineffective recanalization after EVT in cerebral infarction with posterior circulation large vessel occlusion.…”
Section: Discussionmentioning
confidence: 99%
“…Full methods of the MR CLEAN registry have been reported previously. 11 Source data will not be made available because of legislative issues on patient privacy but detailed analytic methods and study materials, including log files of statistical analyses, will be made available to other researchers on reasonable request to the first author. This article adheres to the STROBE guidelines which can be found in the Supplemental Material.…”
Section: Methods Data Source: Mr Clean Registrymentioning
confidence: 99%